Company intelligence / Profile preview

VetCure

California, United States

Ownership: Private
Development stage: Other

Overview

VetCure, Inc. markets Vetericyn Wound Care products, based on the Microcyn Technology, for treating wounds/infections in animals. Over 1 million patients treated (human product) with strong safety and efficacy signals, adopted rapidly in the animal health market.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Biologic (via Vetericyn)Topical antimicrobial solution (oxy-chlorine compounds)
Industry: Veterinary

Partnerships

Oculus Innovative Sciences (exclusive US distribution rights for Vetericyn)Revenue sharing partnership with Oculus

Beyond the preview

Go deeper on VetCure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VetCure.

Explore the full profile